Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor)

Surgery Today

Volumn 29, Issue 6, 1999, Pages 493-503

  Inada, Shigemitsu ^a   Koto, Tsuyoshi ^a   Futami, Kitaro ^a   Arima, Sumitaka ^a   Iwashita, Akinori ^a  

^a Fukuoka University   (Japan)

Author keywords

E cadherin; Epidermal growth factor receptor; Esophageal cancer; P53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CORRELATION FUNCTION; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; JAPAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 0032968713     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02482343     Document Type: Article

References (24)

1. 1. Muroi M (1995) A clinicopathological study on extensive lymph node dissection for thoracic esophageal cancer (in Japanese with English abstract). Nippon Kyobu Geka Gakkai Zasshi (J Jpn Assoc Thorac Surg) 43:287-299
2. 2. Kakegawa T, Yamana H (1995) Progress in surgical treatment of carcinoma of the intrathoracic esophagus (in Japanese with English abstract). Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 22:855-862
3. 3. Kotoh T, Arima S, Inada S, Futami K (1995) A study of lymph node metastasis and recurrence in thoracic esophageal cancer. Med Bull Fukuoka Univ 22:53-60
4. 4. Japanese Society for Esophageal Disease (1992) Guidelines for the clinical and pathological studies on carcinoma of the esophagus, 8th edn. Kinahara, Tokyo
5. 5. Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34:187-220
6. 6. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705-708
7. 7. Wagata T, Ishizaki K, Imamura M, Shimada Y, Ikenaga M, Tobe T (1991) Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res 51:2113-2117
8. 8. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC (1990) Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 87:9958-9961
9. 9. Hollstein MC, Peri L, Mandard AM, Welsh JA, Montesano R, Metcalf RA, Bak M, Harris CC (1991) Genetic analysis of human esophageal tumors from two high-incidence geographic areas: frequent p53 base substitutions and absence of ras mutation. Cancer Res 51:4102-4106
10. 10. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half-life. Mol Cell Biol 8:531-539
11. 11. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE (1994) p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74:2218-2223
12. 12. Goukon Y, Sasano H, Nishihira T, Nagura H, Mori S (1994) p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study. Anticancer Res 14:1305-1312
13. 13. Shimaya K, Shinozaki H, Inoue M, Tahara H, Monden T, Shimano T, Mori T (1993) Significance of p53 expression as a prognostic factor in esophageal squamous cell carcinoma. Virchows Arch (A) 422:271-276
14. 14. Shiozaki H, Miyata M, Kobayashi K, Tahara H, Tamura S, Yano H, Oka H, Doki Y, Iihara K, Mori T, Hirano S, Takeichi M (1991) Correlation between E-cadherin expression and lymphnode metastasis in esophageal cancer (in Japanese with English abstract). Nippon Syoukakigeka Gakkai Zassi (Jpn J Gastroenterol Surg) 24:1117-1120
15. 15. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, Iihara K, Matsui S, Iwazawa T, Nagafuchi A, Tsukita S, Mori T (1994) E-cadherin and α catenin expression in human esophageal cancer. Cancer Res 54:291-296
16. 16. Cohen S, Ushio H, Stoscheck C, Chinkers M (1982) A native 170000 epidermal growth factor receptor kinase complex from shed plasma membrane vesicle. J Biol Chem 257:1523-1531
17. 17. Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S, Shimizu N (1986) High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 46:414-416
18. 18. Lewis S, Locker A, Todd JH, Bell JA, Nicholson R, Elston CW, Blamey RW, Ellis IO (1990) Expression of epidermal growth factor receptor in breast carcinoma. J Clin Pathol 43:385-389
19. 19. Yonemura Y, Sugimati K, Kamata T, Fushida S, Yamaguchi A, Miwa K, Miyazaki I (1988) Correlation of epidermal growth factor receptor status and clinical outcome in gastric carcinoma (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 89:1611-1615
20. 20. Arai M, Hirose K, Nakagawara G, Inuzuka M (1994) Expression of human epidermal growth factor and its receptor of the gastric carcinomas with special reference to DNA ploidy patterns and nucleolar organizer regions (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 95:171-178
21. 21. Yano H, Shiozaki H, Kobayashi K, Yano T, Tahara H, Tamura S, Mori T (1991) Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma. Cancer 67:91-98
22. 22. Itakura Y, Sasano H, Shiga C, Shiga K, Nishihira T, Nagura H, Mori S (1993) Immunohistochemical analysis of epidermal growth factor receptor (EGFR) overexpression in esophageal carcinoma (in Japanese with English abstract). Shokakigan No Hassei To Shinten (J Jpn Res Gastroenterol Carcinogen) 5:195-199
23. 23. Fukuda M, Okamura K, Fujita S, Böhm N, Rohrbach R, Sandritter W (1978) The different stem cell populations in mouse epidermis and lingual epithelium. Pathol Res Pract 163:205-227
24. 24. Fukuyama R, Shimizu N (1991) Detection of epidermal growth factor receptors and E-cadherin in the basolateral membrane of A431 cells by laser scanning florescence microscopy. Jpn J Cancer Res 82:8-11